Overtreating chronic back pain: time to back off? - PubMed (original) (raw)

Review

Overtreating chronic back pain: time to back off?

Richard A Deyo et al. J Am Board Fam Med. 2009 Jan-Feb.

Abstract

Chronic back pain is among the most common patient complaints. Its prevalence and impact have spawned a rapidly expanding range of tests and treatments. Some of these have become widely used for indications that are not well validated, leading to uncertainty about efficacy and safety, increasing complication rates, and marketing abuses. Recent studies document a 629% increase in Medicare expenditures for epidural steroid injections; a 423% increase in expenditures for opioids for back pain; a 307% increase in the number of lumbar magnetic resonance images among Medicare beneficiaries; and a 220% increase in spinal fusion surgery rates. The limited studies available suggest that these increases have not been accompanied by population-level improvements in patient outcomes or disability rates. We suggest a need for a better understanding of the basic science of pain mechanisms, more rigorous and independent trials of many treatments, a stronger regulatory stance toward approval and post-marketing surveillance of new drugs and devices for chronic pain, and a chronic disease model for managing chronic back pain.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: The research program of Drs. Deyo and Mirza has benefited from a gift to the University of Washington from Synthes, a surgical device manufacturer. They have not received any personal financial support from this source. Mr. Martin has received partial salary support from this source. Dr. Turner has no conflicts to declare.

Figures

Figure 1

Figure 1. Increases in Use of Various Services for Low Back Pain

(1a.) Lumbar spine magnetic resonance imaging (CPT codes 72148, 72149, 72158), numbers of scans among Medicare beneficiaries, from Part B claims; (1b.) Numbers of opioid prescriptions for spine conditions, national data from the Medical Expenditure Panel Survey, reference 11 (1c.) Rates of lumbosacral injections in the Medicare population, age- and sex-adjusted. Data are from reference 1, adapted with permission.(1d.) Lumbar spine fusion rates for degenerative conditions, age- and sex-adjusted, National Inpatient Sample, from reference 2, reproduced with permission.

Figure 2

Figure 2. Percentage of individuals with permanent work disability (Social Security Disability Income beneficiaries) disabled by various medical conditions. Data are from reference 24.

Similar articles

Cited by

References

    1. Raofi S, Schappert SM. Medication therapy in ambulatory medical care: United States, 2003-04. National Center for Health Statistics. Vital Health Stat. 2006 December;13(163) - PubMed
    1. Friedly J, Chan L, Deyo R. Increases in lumbosacral injections in the Medicare population:1994-2001. Spine. 2007;32:1754–60. - PubMed
    1. Deyo RA, Gray DT, Kreuter W, Mirza S, Martin BI. United States trends in lumbar fusion surgery for degenerative conditions. Spine. 2005;30:1441–5. - PubMed
    1. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006;81:103–7. - PubMed
    1. Deyo RA, Mirza SK, Martin BI. Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine. 2006;31:2724–7. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources